文献速递心脏核医学

SPECT-MPI在慢性肾脏病中的增量预后价值:一项重分类分析

Incremental prognostic value of SPECT-MPI in chronic kidney disease: A reclassification analysis.
PubMed 文献 · J Nucl Cardiol · 2017-01-03

该回顾性研究纳入2004年4月至2009年5月因临床指征转诊行SPECT-MPI的11,518例患者,评估灌注缺损(TPD)在肾功能连续谱中对心源性死亡和非致死性心肌梗死复合终点的独立与增量预后价值。中位随访5年期间1,692例(14.5%)发生CD/MI,校正传统心血管危险因素和GFR后灌注缺损仍与CD/MI风险独立相关(HR=2.10),TPD使AUC从0.725提高至0.784,NRI=14%、相对IDI=60%。

要点

  • 校正传统心血管危险因素和GFR后,SPECT-MPI灌注缺损与CD/MI风险独立相关(HR=2.10,95%CI 1.81-2.43,p<.001)。
  • TPD使AUC从0.725(95%CI 0.712-0.738)提高至0.784(95%CI 0.772-0.796),p<.0001。
  • TPD在传统危险因素和GFR之上改善风险分层:NRI=14%(95%CI 12%-16%,p<.001),相对IDI=60%(95%CI 51%-66%,p<.001)。

核心结论

  • 在肾功能连续谱中,SPECT-MPI灌注缺损可独立且增量地对CD/MI风险进行重分类,优于传统心血管危险因素。

研究设计与样本

  • 回顾性研究纳入11,518例因临床指征转诊行SPECT-MPI的患者(平均年龄65±12岁,52%为男性),转诊时间范围为2004年4月至2009年5月。
  • 主要终点为心源性死亡和非致死性心肌梗死的复合终点(CD/MI)。
  • 采用多变量Cox回归模型分析总灌注缺损(TPD)与CD/MI的关系,并用Harrell c指数、净重分类指数(NRI)和综合判别指数(IDI)评估TPD的增量预测价值。

主要发现

  • 中位随访5年(第25至75百分位3.0-6.5年)期间,1,692例(14.5%)发生CD/MI(其中心肌梗死740例,心源性死亡1,182例)。
  • 在校正传统心血管危险因素和GFR的多变量模型中,存在灌注缺损与CD/MI风险升高独立相关(HR=2.10;95%CI 1.81-2.43,p<.001)。
  • TPD在传统心血管危险因素和GFR之上改善判别能力,AUC从0.725(95%CI 0.712-0.738)提高至0.784(95%CI 0.772-0.796),p<.0001。
  • TPD在传统心血管危险因素和GFR之上改善CKD患者的风险分层:NRI=14%(95%CI 12%-16%,p<.001),相对IDI=60%(95%CI 51%-66%,p<.001)。

关键数值与推荐

  • 慢性肾脏病定义为肌酐清除率低于60 mL/min/1.73 m²。
  • 灌注缺损与CD/MI的独立关联:HR=2.10(95%CI 1.81-2.43,p<.001)。
  • 判别能力改善:AUC从0.725(95%CI 0.712-0.738)提高至0.784(95%CI 0.772-0.796),p<.0001。
  • 重分类改善:NRI=14%(95%CI 12%-16%,p<.001),相对IDI=60%(95%CI 51%-66%,p<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Traditional cardiovascular (CV) risk factors have limited predictive value of CV mortality in patients with chronic kidney disease (CKD, creatinine clearance less than 60 mL/minute per 1.73 m2). The aim of this study was to evaluate incremental and independent prognostic value of single-photon emission computerized tomography-myocardial perfusion imaging (SPECT-MPI) across continuum of renal function. METHODS: We retrospectively studied 11,518 (mean age, 65 ± 12 years; 52% were men) patients referred for a clinical indication of SPECT-MPI between April 2004 and May 2009. Primary end point was composite of cardiac death and non-fatal myocardial infarction (CD/MI). We examined the relationship of total perfusion defect (TPD) and CD/MI in multiple Cox regression models for CV risk factors and GFR. The incremental predictive value of TPD was examined using Harrell's c-index, net reclassification index (NRI), and integrated discrimination index (IDI). RESULTS: Over a median follow-up of 5 years (25th to 75th percentiles, 3.0-6.5 years), 1,692 (14.5%) patients experienced CD/MI (740 MI and 1,182 CD). In a multivariable model adjusted for traditional CV risk factors and GFR, the presence of a perfusion defect was independently associated with increased risk of CD/MI (HR = 2.10; 95% CI 1.81, 2.43, p < .001). Using Cox regression, TPD improved the discriminatory ability beyond traditional CV risk factors and GFR [from AUC = 0.725, (95% CI 0.712-0.738) to 0.784, (95% CI 0.772-0.796), p < .0001]. Furthermore, TPD improves risk stratification of CKD patients over and above traditional CV risk factors and GFR [NRI = 14%, 95% CI (12%-16%, p < .001) and relative IDI = 60%, 95% CI (51%, 66%, p < .001)]. CONCLUSIONS: Across the spectrum of renal function, SPECT-MPI perfusion defects independently and incrementally reclassified patients for their risk of CD/MI, beyond traditional CV risk factors.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Ahmed AM, Qureshi WT, O'Neal WT, et al. Incremental prognostic value of SPECT-MPI in chronic kidney disease: A reclassification analysis. J Nucl Cardiol. 2017. PMID: 28050863. doi:10.1007/s12350-016-0756-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。